LYMPHOPROLIFERATIVE DISORDER
Clinical trials for LYMPHOPROLIFERATIVE DISORDER explained in plain language.
Never miss a new study
Get alerted when new LYMPHOPROLIFERATIVE DISORDER trials appear
Sign up with your email to follow new studies for LYMPHOPROLIFERATIVE DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cancer drug nivolumab takes on EBV-Linked tumors in new trial
Disease control Recruiting nowThis phase 2 trial tests whether the drug nivolumab can slow or stop the growth of Epstein-Barr virus (EBV)-positive lymphoproliferative disorders and non-Hodgkin lymphomas. About 40 people aged 12 and older whose cancers have not responded to standard therapy will receive nivolu…
Matched conditions: LYMPHOPROLIFERATIVE DISORDER
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New drug combo aims to control lymphoma without chemo
Disease control Recruiting nowThis phase 2 trial is testing a combination of two drugs, acalabrutinib and obinutuzumab, in people with untreated follicular lymphoma or other slow-growing non-Hodgkin lymphomas. The goal is to see if this drug pair can shrink tumors and control the disease. About 49 participant…
Matched conditions: LYMPHOPROLIFERATIVE DISORDER
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New registry aims to unlock secrets of cancer in older adults
Knowledge-focused Recruiting nowThis research study creates a registry of older adults with cancer to collect information about their health, treatments, and outcomes. Participants complete a geriatric assessment and allow researchers to follow their medical records. The goal is to better understand how cancer …
Matched conditions: LYMPHOPROLIFERATIVE DISORDER
Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Massive childhood cancer registry launches to unlock better treatments
Knowledge-focused Recruiting nowThis study is a large registry that collects health information and leftover tumor or blood samples from up to 75,000 children and young adults with cancer. The goal is to track outcomes and gather data to help doctors find better ways to treat and care for these patients over ti…
Matched conditions: LYMPHOPROLIFERATIVE DISORDER
Sponsor: Children's Oncology Group • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Gene clues may explain lingering blood issues after CAR-T
Knowledge-focused Recruiting nowThis study looks at gene changes that might cause low blood cell counts (cytopenia) in people with multiple myeloma or certain lymphomas after CAR-T therapy. About one-third of patients have low blood counts lasting more than 30 days after treatment. Researchers will test blood a…
Matched conditions: LYMPHOPROLIFERATIVE DISORDER
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC
-
Blood cancer Patients' samples fuel future research
Knowledge-focused Recruiting nowThis study collects blood, tissue, and body fluid samples from up to 15,000 people with blood cancers or related disorders. The samples are stored in a central lab for future research on diagnosis, prognosis, and immune monitoring. Participants do not receive any treatment as par…
Matched conditions: LYMPHOPROLIFERATIVE DISORDER
Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC